# Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response

> **NCT01128569** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 52 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fluticasone Furoate
- **DRUG:** FF/Vilanterol (VI; GW642444M)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01128569
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2017-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01128569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01128569, "Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01128569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*